Trial Profile
Plerixafor for stem cell mobilization in patients with multiple myeloma who mobilize moderate to optimize collection results - a randomized, placebo-controlled, double-blind study
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 20 Apr 2017
Price :
$35
*
At a glance
- Drugs Plerixafor (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 20 Apr 2017 New trial record